Allogene Therapeutics, Inc. (ALLO) SEC filings
ALLO SEC filings moved a median of -0.54% by the close. ALLO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ALLO overview →
67 measured ALLO SEC filing events.
Where these ALLO SEC filings landedvs 67 measured ALLO SEC filing reactions
| Middle 50% of ALLO SEC filing reactions | -6.60% to +4.18% |
|---|---|
| Median reaction (to close) | -0.54% |
| Measured reactions | 67 |
Point-in-time · zero look-ahead
Half of the 67 ALLO SEC filing events with a measured close landed between -6.60% and +4.18%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Allogene Therapeutics, For: Aug 31 | SEC filing · Form 8-K | +0.31% | +1.14% | |
| Form 8-K Allogene Therapeutics, For: Aug 31 | SEC filing · Form 8-K | +2.56% | +1.02% | |
| Form EFFECT Allogene Therapeutics, | SEC filing · Form EFFECT | -0.94% | -1.88% | |
| Form 10-Q Allogene Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.73% | -7.91% | |
| Form 8-K Allogene Therapeutics, For: Aug 12 | SEC filing · Form 8-K | -3.73% | -7.91% | |
| Form S-3 Allogene Therapeutics, | SEC filing · Form S-3 | -3.73% | -7.91% | |
| Form 8-K Allogene Therapeutics, For: Jun 18 | SEC filing · Form 8-K | +2.22% | +1.97% | |
| Form 8-K Allogene Therapeutics, For: May 28 | SEC filing · Form 8-K | -4.40% | +0.46% | |
| Form DEFA14A Allogene Therapeutics, | SEC filing · Form DEFA14A | -4.40% | +0.46% | |
| Form DEFA14A Allogene Therapeutics, | SEC filing · Form DEFA14A | -1.64% | +4.25% | |
| Form 10-Q Allogene Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -6.96% | |
| Form 8-K Allogene Therapeutics, For: May 12 | SEC filing · Form 8-K | +0.00% | -6.96% | |
| Form ARS Allogene Therapeutics, For: Dec 31 | SEC filing · Form ARS | +1.87% | +2.87% | |
| Form DEF 14A Allogene Therapeutics, For: Jun 18 | SEC filing · Form DEF | +1.87% | +2.87% | |
| Form DEFA14A Allogene Therapeutics, | SEC filing · Form DEFA14A | +1.87% | +2.87% | |
| Form PRE 14A Allogene Therapeutics, For: Apr 20 | SEC filing · Form PRE | -3.51% | -4.13% | |
| Form 8-K Allogene Therapeutics, For: Apr 14 | SEC filing · Form 8-K | +6.47% | +5.80% | |
| Form 8-K Allogene Therapeutics, For: Apr 13 | SEC filing · Form 8-K | -1.96% | -25.18% | |
| Form 10-K Allogene Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.93% | -6.25% | |
| Form 8-K Allogene Therapeutics, For: Mar 12 | SEC filing · Form 8-K | +2.93% | -6.25% | |
| Form S-8 Allogene Therapeutics, | SEC filing · Form S-8 | +2.93% | -6.25% | |
| Form 10-Q Allogene Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +3.77% | +12.38% | |
| Form 8-K Allogene Therapeutics, For: Nov 06 | SEC filing · Form 8-K | +3.77% | +12.38% | |
| Form 8-K Allogene Therapeutics, For: Sep 26 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q Allogene Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.94% | +1.91% | |
| Form 8-K Allogene Therapeutics, For: Aug 13 | SEC filing · Form 8-K | +1.94% | +1.91% | |
| Form 8-K Allogene Therapeutics, For: Aug 01 | SEC filing · Form 8-K | +1.25% | -10.00% | |
| Form 8-K Allogene Therapeutics, For: Jun 18 | SEC filing · Form 8-K | -1.64% | +2.46% | |
| Form 10-Q Allogene Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.46% | -13.38% | |
| Form 8-K Allogene Therapeutics, For: May 13 | SEC filing · Form 8-K | -0.46% | -13.38% | |
| Form ARS Allogene Therapeutics, For: Dec 31 | SEC filing · Form ARS | +2.29% | +9.80% | |
| Form DEF 14A Allogene Therapeutics, For: Jun 18 | SEC filing · Form DEF | +2.29% | +9.80% | |
| Form DEFA14A Allogene Therapeutics, | SEC filing · Form DEFA14A | +2.29% | +9.80% | |
| Form 10-K Allogene Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -4.43% | |
| Form 8-K Allogene Therapeutics, For: Mar 13 | SEC filing · Form 8-K | +0.00% | -4.43% | |
| Form S-8 Allogene Therapeutics, | SEC filing · Form S-8 | +0.00% | -4.43% | |
| Form 8-K Allogene Therapeutics, For: Feb 19 | SEC filing · Form 8-K | +0.00% | +2.51% | |
| Form 8-K Allogene Therapeutics, For: Jan 23 | SEC filing · Form 8-K | +1.62% | -0.54% | |
| Form 8-K Allogene Therapeutics, For: Nov 11 | SEC filing · Form 8-K | -1.47% | -9.56% | |
| Form 10-Q Allogene Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -5.56% | -4.94% | |
| Form 8-K Allogene Therapeutics, For: Nov 07 | SEC filing · Form 8-K | -5.56% | -4.94% | |
| Form 8-K Allogene Therapeutics, For: Oct 03 | SEC filing · Form 8-K | +0.76% | +6.20% | |
| Form 10-Q Allogene Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -6.92% | -9.23% | |
| Form 8-K Allogene Therapeutics, For: Aug 07 | SEC filing · Form 8-K | -6.92% | -9.23% | |
| Form 8-K Allogene Therapeutics, For: Jun 05 | SEC filing · Form 8-K | -0.83% | +5.37% | |
| Form 8-K Allogene Therapeutics, For: May 24 | SEC filing · Form 8-K | +3.75% | -0.79% | |
| Form 8-K Allogene Therapeutics, For: May 13 | SEC filing · Form 8-K | +6.33% | -0.67% | |
| Form 10-Q Allogene Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +7.38% | -8.92% | |
| Form 8-K Allogene Therapeutics, For: May 13 | SEC filing · Form 8-K | +7.38% | -8.92% | |
| Form EFFECT Allogene Therapeutics, | SEC filing · Form EFFECT | -2.81% | +1.40% | |
| Form ARS Allogene Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.19% | -9.79% | |
| Form DEF 14A Allogene Therapeutics, For: Jun 05 | SEC filing · Form DEF | -1.19% | -9.79% | |
| Form DEFA14A Allogene Therapeutics, | SEC filing · Form DEFA14A | -1.19% | -9.79% | |
| Form 10-K Allogene Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +6.74% | +4.72% | |
| Form 10-K/A Allogene Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +6.74% | +4.72% | |
| Form 8-K Allogene Therapeutics, For: Mar 14 | SEC filing · Form 8-K | +6.74% | +4.72% | |
| Form POSASR Allogene Therapeutics, | SEC filing · Form POSASR | +6.74% | +4.72% | |
| Form S-3 Allogene Therapeutics, | SEC filing · Form S-3 | +6.74% | +4.72% | |
| Form S-8 Allogene Therapeutics, | SEC filing · Form S-8 | +6.74% | +4.72% | |
| Form 8-K Allogene Therapeutics, For: Feb 14 | SEC filing · Form 8-K | -1.63% | -2.25% | |
| Form 8-K Allogene Therapeutics, For: Jan 25 | SEC filing · Form 8-K | -0.24% | -2.22% | |
| Form 8-K Allogene Therapeutics, For: Jan 03 | SEC filing · Form 8-K | -3.57% | +4.11% | |
| Form 8-K Allogene Therapeutics, For: Dec 09 | SEC filing · Form 8-K | -0.66% | -1.32% | |
| Form 10-Q Allogene Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +6.07% | +11.82% | |
| Form 8-K Allogene Therapeutics, For: Nov 02 | SEC filing · Form 8-K | +6.07% | +11.82% | |
| Form 8-K/A Allogene Therapeutics, For: Oct 16 | SEC filing · Form 8-K | -2.19% | -3.45% | |
| Form 8-K Allogene Therapeutics, For: Oct 16 | SEC filing · Form 8-K | -2.50% | +1.25% |
Keep exploring
More ALLO: earnings → · analyst actions → · ALLO overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Dynavax Technologies Corporation (DVAX) | 315 | +0.07% | 55% |
| XOMA Royalty Corporation (XOMA) | 315 | 0.00% | 48% |
| Aptevo Therapeutics Inc. (APVO) | 314 | -0.92% | 33% |
| Myomo Inc. (MYO) | 314 | +0.35% | 54% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.